Upgrade to SI Premium - Free Trial

United Therapeutics (UTHR) PT, Estimate Raised at BMO Capital

July 29, 2014 3:44 PM
BMO Capital analyst Jim Birchenough reiterated an Outperform rating and boosted his price target on United Therapeutics Corp. (NASDAQ: UTHR) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles